Induction of a hypometabolic state during critical illness - a new concept in the ICU?
被引:0
|
作者:
Aslami, H.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Amsterdam, Acad Med Ctr, LEICA, NL-1105 AZ Amsterdam, NetherlandsUniv Amsterdam, Acad Med Ctr, LEICA, NL-1105 AZ Amsterdam, Netherlands
Aslami, H.
[1
]
Juffermans, N. P.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Amsterdam, Acad Med Ctr, LEICA, NL-1105 AZ Amsterdam, Netherlands
Univ Amsterdam, Acad Med Ctr, Dept Intens Care Med, NL-1105 AZ Amsterdam, NetherlandsUniv Amsterdam, Acad Med Ctr, LEICA, NL-1105 AZ Amsterdam, Netherlands
Juffermans, N. P.
[1
,2
]
机构:
[1] Univ Amsterdam, Acad Med Ctr, LEICA, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Intens Care Med, NL-1105 AZ Amsterdam, Netherlands
来源:
NETHERLANDS JOURNAL OF MEDICINE
|
2010年
/
68卷
/
05期
Induced hypothermia after cardiopulmonary resuscitation provides organ protection and is currently considered standard of care in clinical practice. An increasing number of reports indicate that induced hypothermia is also beneficial in other conditions of hypoxia-induced organ injury, including brain injury, intestinal ischaemia-reperfusion injury and acute lung injury. The mechanism of the protective effect is thought to be caused by a reduction in metabolism. A hibernation-like state, characterised by hypothermia, bradypnoea and a reduction in metabolic rate, was induced in animals that normally do not hibernate, after inhalation of hydrogen sulphide. This state was termed a 'suspended animation-like state'. In critically ill patients, an exaggerated systemic inflammatory response is common, which often results in multiple organ injury. Inducing a hypometabolic state during critical illness may limit organ injury by reducing oxygen consumption, constituting a fascinating new therapeutic perspective for the treatment of critically ill patients. In this manuscript, we describe mitochondrial dysfunction during critical illness and preclinical data that suggest a potential therapeutic possibility of lowering metabolism. In addition, we discuss issues that warrant further research before clinical applicability.
机构:
Karolinska Inst, Global Publ Hlth, Stockholm, Sweden
Uppsala Univ, Ctr Clin Res Sormland, Eskilstuna, Sweden
Nykoping Hosp, Internal Med, Nykoping, SwedenKamuzu Univ Hlth Sci, Publ Hlth, Blantyre, Malawi
Schell, Carl Otto
Warnberg, Martin Gerdin
论文数: 0引用数: 0
h-index: 0
机构:
Karolinska Inst, Global Publ Hlth, Stockholm, Sweden
Karolinska Univ Hosp, Periopei Ative Med & Intens Care, Stockholm, SwedenKamuzu Univ Hlth Sci, Publ Hlth, Blantyre, Malawi